Decode
is a Private company. Chase Spurlock is the Co-Founder & CEO of Decode and has an approval rating of 90 from Owler members. Decode's top competitor is Perception Health, led by Gregg Loughman, who is their CEO. Decode has 4 followers on Owler.Decode
is a Private company. Chase Spurlock is the Co-Founder & CEO of Decode and has an approval rating of 90 from Owler members. Decode's top competitor is Perception Health, led by Gregg Loughman, who is their CEO. Decode has 4 followers on Owler.
News
May 29, 2026
Decode Blog
Decode Blog Associations between perfluoroalkyl substances and multiple sclerosis in U.S. cohorts compared with NMOSD, MOGAD, and healthy controls
May 06, 2026
PRWeb
Press Release: Decode : Decode Health and Circular Genomics Announce a Research Collaboration to Advance Circular RNA Biomarkers in Multiple Sclerosis
Apr 10, 2026
Decode Blog
Decode Blog Pre-Analytical RNA Integrity Assessment for Sequencing-Based Biomarker Discovery
Apr 08, 2026
Decode Blog
Decode Blog Genome Biology: ImmuSeeker: deep mining of immune-related gene family signatures through lineage reconstruction
Mar 19, 2026
Decode Blog
Decode Blog Whole-blood RNA and plasma NfL correlations identify biomarker candidates and targetable pathways in MS and NMO
Mar 19, 2026
Decode Blog
Decode Blog Predicting Rising Risk in Crohn's Disease Before the Spending Hits
Mar 19, 2026
Decode Blog
Decode Blog BMJ: Machine learning framework for early identification of high-spending Crohn's disease patients using administrative claims
Jan 07, 2026
Decode Blog
Decode Blog Decode Health's AI Platform Flags Imminent High-Cost Risk in MS
Jan 07, 2026
Decode Blog
Decode Blog Communications Medicine: Multiple sclerosis risk stratification and healthcare cost prediction using machine learning
Nov 14, 2025
Decode Blog
Decode Blog NIH's 2026-2030 Autoimmune Disease Research Roadmap: Why it matters and how Decode Health is leaning in
Decode Competitors
1
2
3
4
5
6
7
8
9
10